Literature DB >> 15549976

Cardiovascular effects of xenon and nitrous oxide in patients during fentanyl-midazolam anaesthesia.

T Goto1, P Hanne, Y Ishiguro, F Ichinose, Y Niimi, S Morita.   

Abstract

Xenon anaesthesia appears to have minimal haemodynamic effects. The purpose of this randomised prospective study was to compare the cardiovascular effects of xenon and nitrous oxide in patients with known ischaemic heart disease. In 20 patients who were due to undergo coronary artery bypass graft surgery, 30 min following induction of anaesthesia with fentanyl 30 microg x kg(-1) and midazolam 0.1 mg x kg(-1) but prior to the start of surgery, xenon or nitrous oxide 60% was administered for 15 min. The results showed that xenon caused a minimal decrease in the mean arterial pressure (from 81 (7) to 75 (8) mmHg, mean (SD)), but did not affect the systolic function of the left ventricle, as demonstrated by unchanged left ventricular stroke work index (LVSWI) and the fractional area change of the left ventricle (FAC) derived from transoesophageal echocardiography (TOE). However, in contrast, nitrous oxide was found to decrease the mean arterial pressure (from 81 (8) to 69 (7) mmHg), the LVSWI, and the FAC. The cardiac index, central venous and pulmonary artery occlusion pressures, systemic and pulmonary vascular resistances, and the TOE-derived E/A ratio through the mitral valve were unchanged by xenon or nitrous oxide. We conclude that xenon provides improved haemodynamic stability compared with nitrous oxide, conserving the left ventricular systolic function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15549976     DOI: 10.1111/j.1365-2044.2004.03900.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  6 in total

1.  Xenon offers stable haemodynamics independent of induced hypothermia after hypoxia-ischaemia in newborn pigs.

Authors:  Elavazhagan Chakkarapani; Marianne Thoresen; Xun Liu; Lars Walloe; John Dingley
Journal:  Intensive Care Med       Date:  2011-12-13       Impact factor: 17.440

Review 2.  Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection.

Authors:  Robert Dickinson; Nicholas P Franks
Journal:  Crit Care       Date:  2010-08-12       Impact factor: 9.097

Review 3.  Neuroprotective Properties of Xenon.

Authors:  Mervyn Maze; Timo Laitio
Journal:  Mol Neurobiol       Date:  2019-11-22       Impact factor: 5.590

4.  Safety and feasibility of xenon as an adjuvant to sevoflurane anaesthesia in children undergoing interventional or diagnostic cardiac catheterization: study protocol for a randomised controlled trial.

Authors:  Sarah Devroe; Jurgen Lemiere; Marc Van de Velde; Marc Gewillig; Derize Boshoff; Steffen Rex
Journal:  Trials       Date:  2015-03-04       Impact factor: 2.279

5.  Xenon consumption during general surgery: a retrospective observational study.

Authors:  Christian Stoppe; Achim Rimek; Rolf Rossaint; Steffen Rex; Ana Stevanovic; Gereon Schälte; Astrid Fahlenkamp; Michael Czaplik; Christian S Bruells; Christian Daviet; Mark Coburn
Journal:  Med Gas Res       Date:  2013-06-11

Review 6.  Update of the organoprotective properties of xenon and argon: from bench to beside.

Authors:  Roehl Anna; Rossaint Rolf; Coburn Mark
Journal:  Intensive Care Med Exp       Date:  2020-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.